Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artículo
|
![]() |
0001 ANALYSIS OF THE ENTIRE HLA REGION IN SUSCEPTIBILITY FOR CERVICAL CANCER: A COMPREHENSIVE STUDYvan der Zee, A. G. ; Nolte, I. J. ; Zoodsma, M. ; Schipper, M. ; Steege, G. Ter ; Oosterom, E. ; de Vries, E. G. ; Te Meerman, G. J.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.51-51 [Revista revisada por pares]Oxford: BMJ Publishing Group LTDTexto completo disponible |
2 |
Material Type: Artículo
|
![]() |
00010 ANTIANGIOGENESIS - A NEW TREATMENT MODALITY FOR OVARIAN CANCER PATIENTSSchröder, W. ; Abadie, S. ; Witteveen, P. O. ; Campone, M. ; Viens, P. ; Jalava, T. ; Masson, E. ; Bilic, S. ; Chlistalla, A. ; du Bois, A.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.53-54 [Revista revisada por pares]Oxford: BMJ Publishing Group LTDTexto completo disponible |
3 |
Material Type: Artículo
|
![]() |
000101 PACLITAXEL/CARBOPLATIN (TC) VS. PACLITAXEL/CARBOPLATIN FOLLOWED BY TOPOTECAN (TOP) IN FIRST-LINE TREATMENT OF OVARIAN CANCER FIGO STAGES IIB-IV. MATURE RESULTS OF AN INTERGROUP PHASE III TRIALLück, H. J. ; Weber, B. ; Quaas, J. ; Lortholary, A. ; SchadeBrittinger, C. ; Richter, B. ; Bourgeois, H. ; Kuhn, W ; Meyer, F. ; Pfisterer, J.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.79-79 [Revista revisada por pares]Oxford: BMJ Publishing Group LTDTexto completo disponible |
4 |
Material Type: Artículo
|
![]() |
000102 PROGRESS IN THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS)Jacobs, I. J. ; Mackay, J. ; Rosenthal, A. N. ; Fraser, L. ; Perault, L. ; Mozersky, J. ; Skates, S. J. ; Menon, U.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.80-80 [Revista revisada por pares]Oxford: BMJ Publishing Group LTDTexto completo disponible |
5 |
Material Type: Artículo
|
![]() |
000103 PACLITAXEL-CARBOPLATIN-GEMCITABINE VS. PACLITAXEL-CARBOPLATIN AS FIRSTLINE TREATMENT OF OVARIAN CANCER: A RANDOMIZED PHASE III GCIG INTERGROUP STUDY (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102)du Bois, A. ; Schroeder, W. ; Jelic, S. ; Weber, B. ; Sehouli, J. ; Keern, J. ; Priou, F. ; Huober, J. ; Railing, M. ; Ray-Coquard, I. ; Heilmann, V. ; Surges, A. ; Pfisterer, J. ; Gropp, M. ; Staehle, A. ; Wimberger, P. ; Jackisch, C. ; Mueller, H. H.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.80-80 [Revista revisada por pares]Oxford: BMJ Publishing Group LTDTexto completo disponible |
6 |
Material Type: Artículo
|
![]() |
000104 POTENTIAL INFLUENCE OF FAMILY HISTORY AND ENVIRONMENTAL FACTORS ON THE PENETRANCE OF BRCA1/BRCA2 MUTATIONSBeller, U.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.80-80 [Revista revisada por pares]Oxford: BMJ Publishing Group LTDTexto completo disponible |
7 |
Material Type: Artículo
|
![]() |
00011 PHASE II STUDY OF FIRST-LINE CARBOPLATIN FOLLOWED SEQUENTIALLY BY GEMCITABINE AND PACLITAXEL IN ADVANCED OVARIAN CANCER: AN AUSTRALIAN AND NEW ZEALAND GYNAECOLOGICAL ONCOLOGY GROUP STUDYFriedlander, M. ; Harnett, P. ; Findlay, M. ; Wyld, D. ; Buck, M.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.54-54 [Revista revisada por pares]Oxford: BMJ Publishing Group LTDTexto completo disponible |
8 |
Material Type: Artículo
|
![]() |
00012 CYTOREDUCTIVE SURGERY PLUS INTRAPERITONEAL HYPERTHERMIC PERFUSION IN THE TREATMENT OF RECURRENT EPITHELIAL OVARIAN CANCERMueller, H. ; Hahn, M.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.54-54 [Revista revisada por pares]Oxford: BMJ Publishing Group LTDTexto completo disponible |
9 |
Material Type: Artículo
|
![]() |
00013 PRIMARY SURGERY OR NEOADJUVANT CHEMOTHERAPY IN THE TREATMENT OF ADVANCED STAGE EPITHELIAL OVARIAN CANCERGungor, M. ; Ortac, F. ; Sonmezer, M.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.54-55 [Revista revisada por pares]Oxford: BMJ Publishing Group LTDTexto completo disponible |
10 |
Material Type: Artículo
|
![]() |
00014 A PHASE II STUDY OF THE AGO OVARIAN CANCER STUDY GROUP (AGO-OVAR 2.6): ZD1839 IN COMBINATION WITH TAMOXIFEN IN REFRACTORY OVARIAN CANCERSehouli, J. ; Wagner, U. ; du Bois, A. ; Pfisterer, J. ; Houber, J. ; Loibl, S. ; Lueck, H. J. ; Gropp, M. ; Staehle, A. ; Schmalfeldt, B. ; Meier, W. ; Jackisch, C.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.55-55 [Revista revisada por pares]Oxford: BMJ Publishing Group LTDTexto completo disponible |